SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC
FORM 12b-25
Commission File Number 0-22340
NOTIFICATION OF LATE FILING
(Check One): [X] Form 10-K [ ] Form 11-K [ ] Form 20-F [ ] Form 10-Q [ ] Form
N-SAR
For Period Ended December 31, 1996
[ ] Transition Report on Form 10-K [ ] Transition Report on Form 10-Q
[ ] Transition Report on Form 20-K [ ] Transition Report on Form N-SAR
[ ] Transition Report on Form 11-K
For the Transition Period Ended:
READ ATTACHED INSTRUCTION SHEET BEFORE PREPARING FORM. PLEASE PRINT OR
TYPE.
Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.
If the notification relates to a portion of the filing checked above,
identify the Item(s) to which the notification relates:
PART I. REGISTRANT INFORMATION
Full name of registrant: Palomar Medical Technologies, Inc.
Former Name (if applicable):
Address of principal executive office
(Street and number): 66 Cherry Hill Drive
City, State and Zip Code: Beverly, Massachusetts 01915
<PAGE>
2
PART II. RULE 12B-25 (B) AND (C)
If the subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed. (Check appropriate box.)
[X] (a) The reasons described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort or expense;
[X] (b) The subject annual report, semi-annual report, transition report on
Form 10-K, 20-F, 11-K or Form N-SAR, or portion thereof will be filed on or
before the 15th calendar day following the prescribed due date; or the subject
quarterly report or transition report on Form 10-Q, or portion thereof will be
filed on or before the fifth calendar day following the prescribed due date; and
[ ] (c) The accountant's statement or other exhibit required by Rule
12b-25(c) has been attached if applicable.
PART III. NARRATIVE
State below in reasonable detail the reasons why Form 10-K, 11-K, 20-F,
10-Q, N-SAR or the transition report portion thereof could not be filed within
the prescribed time period, (Attach extra sheets if needed.)
Palomar Medical Technologies, Inc. (the "Company") is unable to meet its
filing date for the Form 10-K for the year ended December 31, 1996 without
unreasonable effort or expense. The Company has requested further advice
from its accountants, legal counsel and unrelated third parties regarding
certain matters which impact the Company's Form 10-K and financial
disclosure to be included therein. As such, the Company is requesting an
extension on this Form 12b-25. The Company intends to file the Form 10-K
within the time period specified by Rule 12b-25 of the Securities Exchange
Act of 1934, as amended
PART IV. OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this
notification:
Joseph P. Caruso (508)921-9300
(2) Have all other periodic reports required under Section 13 or 14(d) of
the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act
of 1940 during the preceding 12 months or for such shorter period that the
registrant was required to file such report(s) been filed? If the answer is no,
identify report(s).
[X] Yes [ ] No
<PAGE>
3
(3) Is it anticipated that any significant change in results of operations
from the corresponding period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or potion thereof?
[X] Yes [ ] No
If so: attach an explanation of the anticipated change, both narratively
and quantitatively, and, if appropriate, state the reasons why a reasonable
estimate of the results cannot be made.
The Company currently anticipates that its loss from operations will be
approximately $39.6 million for the year ended December 31, 1996 as compared
with a loss from operations of $12.5 million for the year ended December 31,
1995. The Company also currently anticipates that it will have a net loss of
approximately $37.9 million for the year ended December 31, 1996 as compared
with the net loss of $12.6 million for the year ended December 31, 1995.
<PAGE>
4
PALOMAR MEDICAL TECHNOLOGIES, INC.
(Name of registrant as specified in charter)
Has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.
Date: March 28, 1997 By: /s/
------------------------------
Joseph P. Caruso
Chief Financial Officer
Instruction. The form may be signed by an executive officer of the
registrant or by any other duly authorized representative. The name and title of
the person signing the form shall be typed or printed beneath the signature. If
the statement is signed on behalf of the registrant by an authorized
representative (other than an executive officer), evidence of the
representative's authority to sign on behalf of the registrant shall be filed
with the form.
ATTENTION
Intentional misstatements or omissions of fact constitute Federal criminal
violations (see 18 U.S.C. 1001).
